Targeted therapies are drugs designed to specifically attack cancer cells without harming normal cells. These drugs often involve complex biologics, such as monoclonal antibodies, which are produced through biotechnological processes involving living cells. The manufacturing process involves cell culture, purification, and formulation, followed by extensive testing to ensure efficacy and safety.
